APA (7th ed.) Citation

E, C., H, T., N, D., I, L., B, M., M, H., . . . SA, S. (2022). Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor. Experimental dermatology, 31(5), 775. https://doi.org/10.1111/exd.14514

Chicago Style (17th ed.) Citation

E, Cohen-Barak, et al. "Concomitant Variants in NF1, LZTR1 and GNAZ Genes Probably Contribute to the Aggressiveness of Plexiform Neurofibroma and Warrant Treatment with MEK Inhibitor." Experimental Dermatology 31, no. 5 (2022): 775. https://doi.org/10.1111/exd.14514.

MLA (9th ed.) Citation

E, Cohen-Barak, et al. "Concomitant Variants in NF1, LZTR1 and GNAZ Genes Probably Contribute to the Aggressiveness of Plexiform Neurofibroma and Warrant Treatment with MEK Inhibitor." Experimental Dermatology, vol. 31, no. 5, 2022, p. 775, https://doi.org/10.1111/exd.14514.